Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities

Melanoma is characterized by high glucose uptake, partially mediated through elevated pyruvate dehydrogenase kinase (PDK), making PDK a potential treatment target in melanoma. We aimed to reduce glucose uptake in melanoma cell lines through PDK inhibitors dichloroacetate (DCA) and AZD7545 and throug...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiersma, Jiske F., Evers, Bernard, Bakker, Barbara M., Jalving, Mathilde, de Jong, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999016/
https://www.ncbi.nlm.nih.gov/pubmed/35409102
http://dx.doi.org/10.3390/ijms23073745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999016/
https://www.ncbi.nlm.nih.gov/pubmed/35409102
http://dx.doi.org/10.3390/ijms23073745

Ejemplares similares